Blogs
Healthcare and Medtech Research Reports
Aug 21, 2023
On August 04, 2023, the FDA has approved Biogen and Sage Therapeutics' Zuranolone as the first tablet for postpartum depression treatment.
Read More...
Jul 17, 2023
Inflammatory Myositis Treatment space is evolving immensely. Companies like Pfizer, Priovant, Argenx are developing new therapies
Read More...
Jul 05, 2023
The demand for Nutricosmetics product is growing at an immense pace. Nutricosmetics market is expected to grow at a CAGR of 8.20% by 2028
Read More...
Jun 21, 2023
Simulations play a key role in the healthcare industry and are an essential part of medical training. It holds immense potential to improve patient safety by providing safe environments for practice and skill development to healthcare professionals. Furthermore, it enables the detection and mitigation of errors, wh...
Read More...
May 22, 2023
Chondrosarcoma is a group of bone tumors made up of cells that make too much cartilage. As per DelveInsight analysis, the total incident cases of chondrosarcoma in the 7MM comprised approximately 2,331 cases in 2022 and are projected to increase during the forecasted period. Our estimates suggest that the United St...
Read More...
May 08, 2023
The discovery of cell and gene therapies has opened up new possibilities for the treatment of rare diseases, especially in Japanese population
Read More...
May 05, 2023
Despite many clinically failed attempts, GSK finally set to launch RSVPreF3, the first preventive respiratory syncytial virus vaccine.
Read More...
May 03, 2023
Cancer is a global burden, leading to a significant number of death and disabilities worldwide. In 2020, nearly one in six deaths were related to cancer. Breast cancer, lung cancer, colon and rectum cancer, and prostate cancer are some of the major cancer types, registering the highest number of cases globally. To ...
Read More...
May 01, 2023
The future of diabetes treatment is changing, as several companies are working on new treatment options for type 1 and type 2 diabetes.
Read More...
Apr 28, 2023
Recent approvals of ADCs for DLBCL treatment, such as Roche's POLIVY & ADC Therapeutics' ZYNLONTA, given patients & physicians renewed hope.
Read More...
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Aug 05, 2026
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Newsletter/Whitepaper